Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.41
Bid: 1.35
Ask: 1.45
Change: 0.00 (0.00%)
Spread: 0.10 (7.407%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.41
RTW Live PriceLast checked at -
RTW Venture is an Investment Trust

To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

1 Jun 2023 07:00

RNS Number : 2247B
RTW Venture Fund Limited
01 June 2023
 

LEI: 549300Q7EXQQH6KF7Z84

1 June 2023

RTW Venture Fund Limited

Notice of Annual General Meeting

RTW Venture Fund Limited (the "Company") announces that its Annual General Meeting ("AGM") will be held at 1st Floor Royal Chambers, St Julian's Avenue St Peter Port, Guernsey on 21 June 2023 at 2pm BST. The Notice of AGM was dispatched to all shareholders on 31 May 2023.

A copy of the Notice of AGM has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism The Notice of AGM may also be viewed on the Company's website at https://www.rtwfunds.com/venture-fund/.

The Annual Report and Audited Financial Statements for the year ended 31 December 2022 (the "Annual Report") is also available on the Company's website https://www.rtwfunds.com/venture-fund/ at  and on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

You will not have received a hard copy proxy form for the AGM in the post. You can instead submit your proxy vote electronically by accessing the shareholder portal at www.signalshares.com, logging in and selecting the 'Vote Online Now' link. Full details of how to vote are set out in the Notes to the Notice of Meeting. Please submit your proxy vote so as to reach the Company's registrar as soon as possible and in any event no later than 2pm BST on 19 June 2023 or, if you are a CREST member, by using the service provided by Euroclear. The completion of the form of proxy will not preclude a member from attending and voting in person at the meeting if it is so allowed.

If any shareholder has questions related to the business of the AGM, please submit your queries to RTWVentureFund@rtwfunds.com by 2pm BST on 19 June 2023. We will endeavour to answer every shareholder question and responses will be posted on the Company's website after the AGM.

For Further Information

RTW Investments, LP

+44 (0)20 7959 6361

Woody Stileman, Managing Director

Krisha McCune, Director, Client Service

 

 

 

Buchanan Communications

+44 (0)20 7466 5107

Charles Ryland

 

Henry Wilson

 

George Beale

 

 

 

About RTW Venture Fund Limited:

RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund Limited invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the RTW website at www.rtwfunds.com for more information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOASDDFIFEDSEDI
Date   Source Headline
13th Nov 20206:22 pmRNSAnnouncement of Share Issuance
13th Nov 20207:00 amRNSNet Asset Value(s)
10th Nov 20209:26 amRNSHolding(s) in Company
9th Nov 20202:00 pmRNSNew Investment in Prometheus Biosciences
2nd Nov 20207:00 amRNSTotal Voting Rights
28th Oct 20201:25 pmRNSHolding(s) in Company
19th Oct 20207:01 amRNSTarsus Pharmaceuticals Prices $88 Million IPO
19th Oct 20207:00 amRNSQuarterly Update
16th Oct 20205:19 pmRNSIssue of Equity
14th Oct 20202:31 pmRNSAnnouncement of Share Issuance
14th Oct 20207:00 amRNSNet Asset Value(s)
5th Oct 20207:00 amRNSC4 Therapeutics Prices $182 Million IPO
2nd Oct 20207:00 amRNSPulmonx Prices $190 Million IPO
28th Sep 20204:13 pmRNSHolding(s) in Company
24th Sep 20207:00 amRNSInterim Report for the period ended 30 June 2020
21st Sep 20207:00 amRNSAthira Pharma Prices $204.0 Million IPO
15th Sep 20207:00 amRNSNet Asset Value(s)
14th Sep 20201:00 pmRNSSeries B Financing Round in NiKang Therapeutics
2nd Sep 20207:00 amRNSNotice of Interim Report
1st Sep 20207:00 amRNSTotal Voting Rights
17th Aug 20205:16 pmRNSIssue of Equity
14th Aug 20202:01 pmRNSAnnouncement of Share Issuance
14th Aug 20207:00 amRNSNet Asset Value(s)
12th Aug 20207:00 amRNSPortfolio Company Update
3rd Aug 20207:00 amRNSTotal Voting Rights
28th Jul 20206:25 pmRNSHolding(s) in Company
27th Jul 20207:00 amRNSiTeos Therapeutics Prices $201 Million IPO
23rd Jul 202012:00 pmRNSNew Investment in Milestone Pharmaceuticals
22nd Jul 20201:00 pmRNSSeries D Financing in Encoded Therapeutics
21st Jul 20207:00 amRNSQuarterly Update
17th Jul 202011:44 amRNSIssue of Equity - Replacement Announcement
17th Jul 20207:00 amRNSIssue of Equity
16th Jul 20206:08 pmRNSAnnouncement of further Share Issuance
16th Jul 20207:00 amRNSIssue of Equity
15th Jul 20207:00 amRNSNet Asset Value(s)
25th Jun 20206:08 pmRNSResult of AGM
22nd Jun 20201:59 pmRNSAGM Statement
16th Jun 20201:15 pmRNSSeries B Financing in C4 Therapeutics
16th Jun 20207:00 amRNSUpdate on Avidity Biosciences IPO
12th Jun 20209:33 amRNSAvidity Biosciences Prices $259.2 Million IPO
12th Jun 20207:00 amRNSNet Asset Value(s)
4th Jun 202012:30 pmRNSSeries B Financing in Athira Pharma
1st Jun 20207:00 amRNSTotal Voting Rights
21st May 20204:00 pmRNSNotice of AGM
19th May 20205:40 pmRNSIssue of Equity
18th May 20207:00 amRNSAnnouncement of Share Issuance
14th May 20207:00 amRNSNet Asset Value(s)
1st May 20207:00 amRNSTotal Voting Rights
28th Apr 20204:36 pmRNSDirector/PDMR Shareholding
28th Apr 20204:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.